CASIA OpenIR
(本次检索基于用户作品认领结果)

浏览/检索结果: 共3条,第1-3条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 15
作者:  Xiong, Kai;  Zhang, Hejun;  Du, Yang;  Tian, Jie;  Ding, Shigang
收藏  |  浏览/下载:197/0  |  提交时间:2019/12/16
Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 11
作者:  Liang, Qian;  Kong, Lingxin;  Du, Yang;  Zhu, Xu;  Tian, Jie
Adobe PDF(2847Kb)  |  收藏  |  浏览/下载:413/101  |  提交时间:2019/12/16
Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging 期刊论文
CANCER LETTERS, 2019, 卷号: 453, 页码: 74-83
作者:  Liu, Shengnan;  Du, Yang;  Ma, He;  Liang, Qian;  Zhu, Xu;  Tian, Jie
收藏  |  浏览/下载:240/0  |  提交时间:2019/07/12
Hepatocellular carcinoma  Regorafenib  Sorafenib  Molecular imaging  Therapeutic effects